HER2-positive gastric cancer

por Boku, Narikazu
Publicado 2013

Real‐world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide database

por Okuyama, Ayako, Boku, Narikazu, Higashi, Takahiro
Publicado 2021

Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer

por Kudo-Saito, Chie, Boku, Narikazu, Hirano, Hidekazu, Shoji, Hirokazu
Publicado 2022

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508

por Kurokawa, Yukinori, Muto, Manabu, Minashi, Keiko, Boku, Narikazu, Fukuda, Haruhiko
Publicado 2009

CD11b(+)CTLA4(+) myeloid cells are a key driver of tumor evasion in colorectal cancer

por Imazeki, Hiroshi, Ogiwara, Yamato, Kawamura, Mami, Boku, Narikazu, Kudo-Saito, Chie
Publicado 2021

Case report: Irinotecan-induced interstitial lung disease in an advanced colorectal cancer patient resurfacing decades after allogeneic bone marrow transplantation for aplastic ane...

por Baba, Keisuke, Matsubara, Yasuo, Hirata, Yoshihiro, Ota, Yasunori, Takahashi, Satoshi, Boku, Narikazu
Publicado 2023

Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies

por Doi, Toshihiko, Boku, Narikazu, Onozawa, Yusuke, Takahashi, Keishiro, Kawaguchi, Osamu, Ohtsu, Atsushi
Publicado 2020

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)

por Shoji, Hirokazu, Takahari, Daisuke, Hara, Hiroki, Nagashima, Kengo, Adachi, Jun, Boku, Narikazu
Publicado 2021

Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study

por Komatsu, Yoshito, Hironaka, Shuichi, Tanizawa, Yoshinori, Cai, Zhihong, Piao, Yongzhe, Boku, Narikazu
Publicado 2021

Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemothe...

por Sakamaki, Kentaro, Kito, Yosuke, Yamazaki, Kentaro, Izawa, Naoki, Tsuda, Takashi, Morita, Satoshi, Boku, Narikazu
Publicado 2017

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer

por Oshima, Kotoe, Hirano, Hidekazu, Shoji, Hirokazu, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Boku, Narikazu
Publicado 2022

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

por Boku, Narikazu, Muro, Kei, Machida, Nozomu, Hashigaki, Satoshi, Kimura, Nobuyuki, Suzuki, Mie, Lechuga, Mariajose, Miyata, Yoshinori
Publicado 2013

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado 2014

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado 2015

Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor‐node‐metastasis classification of colorectal cancer and the 9th...

por Shida, Dai, Boku, Narikazu, Nakamura, Yuya, Yoshida, Takefumi, Tanabe, Taro, Yasui, Kohei, Takashima, Atsuo, Kanemitsu, Yukihide
Publicado 2021

Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after che...

por Yamaguchi, Kensei, Boku, Narikazu, Muro, Kei, Yoshida, Kazuhiro, Baba, Hideo, Tanaka, Shinji, Akamatsu, Ayumi, Sano, Takeshi
Publicado 2021

Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer

por Imaizumi, Jun, Shida, Dai, Boku, Narikazu, Igaki, Hiroshi, Itami, Jun, Miyakita, Yasuji, Narita, Yoshitaka, Takashima, Atsuo, Kanemitsu, Yukihide
Publicado 2023

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer

por Doi, Toshihiko, Yoshino, Takayuki, Fuse, Nozomu, Boku, Narikazu, Yamazaki, Kentaro, Koizumi, Wasaburo, Shimada, Ken, Takinishi, Yasutaka, Ohtsu, Atsushi
Publicado 2015

Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan

por Shida, Dai, Ahiko, Yuka, Tanabe, Taro, Yoshida, Takefumi, Tsukamoto, Shunsuke, Ochiai, Hiroki, Takashima, Atsuo, Boku, Narikazu, Kanemitsu, Yukihide
Publicado 2018

Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer

por Takamizawa, Yasuyuki, Shida, Dai, Boku, Narikazu, Nakamura, Yuya, Ahiko, Yuka, Yoshida, Takefumi, Tanabe, Taro, Takashima, Atsuo, Kanemitsu, Yukihide
Publicado 2020